So we have a small pharmaceutical company backed by some pretty big investors, that's been forced to go public in order to raise more funds to continue manufacturing and testing Prolanta, a drug that is showing efficacy and no adverse effects. And it's only trading at .05-.06!? Redman could've easily just sold this whole operation over to a larger pharmaceutical company. I mean, he's been sitting on this company for 10+ years, but obviously he and his investors are holding on to Oncolix/Prolanta for a reason.
What absolute gift we have here to be able to own a piece of this at such low prices.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.